Table 2 Overall (TCGA) and disease-specific (individual and combined European cohorts) survival analyses

From: Integrated analysis of cervical squamous cell carcinoma cohorts from three continents reveals conserved subtypes of prognostic significance

 

Univariate

Multivariate

HR

p value (Log rank)

95% CI

HR

p value (Wald)

95% CI

TCGAa

C1

–

–

–

–

–

–

C2

2.37

0.003

1.42, 4.56

2.37

0.019

1.16, 4.88

Bergenb

C1

–

–

–

–

–

–

C2

5.28

0.07

0.87, 31.9

98.1

<0.001

8.41, 1145

Innsbruckb

C1

–

–

–

–

–

–

C2

0.55

0.6

0.07, 4.26

1.23

0.9

0.06, 24.9

Oslob

C1

–

–

–

–

–

–

C2

1.69

0.07

0.96, 3.14

2.17

0.019

1.14, 4.13

Europe combinedb

C1

–

–

–

–

–

–

C2

1.67

0.05

0.99, 2.90

2.32

0.004

1.30, 4.13

  1. aMultivariate analysis included age, tumour stage and HPV type as covariates.
  2. bMultivariate analysis included age, tumour stage, HPV type and treatment regimen as covariates.
Back to article page